User profiles for Shantan Reddy

Shantan Reddy

University of Pennsylvania
Verified email at pennmedicine.upenn.edu
Cited by 1356

Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells

…, AP Cogdill, JJD Morrissette, JE DeNizio, S Reddy… - Nature, 2018 - nature.com
Cancer immunotherapy based on genetically redirecting T cells has been used successfully
to treat B cell malignancies 1 , 2 – 3 . In this strategy, the T cell genome is modified by …

[HTML][HTML] Rapid manufacturing of non-activated potent CAR T cells

…, KD Cummins, G Plesa, VA Cantu, S Reddy… - Nature biomedical …, 2022 - nature.com
Chimaeric antigen receptor (CAR) T cells can generate durable clinical responses in B-cell
haematologic malignancies. The manufacturing of these T cells typically involves their …

[HTML][HTML] Randomized phase II trial of gemcitabine plus TH-302 versus gemcitabine in patients with advanced pancreatic cancer

MJ Borad, SG Reddy, N Bahary, HE Uronis… - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
… Provision of study materials or patients: Shantan G. Reddy, Hope E. Uronis, Allen L. Cohn,
William R. … Reddy, Nathan Bahary, Hope E. Uronis, Allen L. Cohn, William R. …

Signatures of COVID-19 severity and immune response in the respiratory tract microbiome

…, J Graham-Wooten, LA Khatib, AS Fitzgerald, S Reddy… - MBio, 2021 - Am Soc Microbiol
Viral infection of the respiratory tract can be associated with propagating effects on the airway
microbiome, and microbiome dysbiosis may influence viral disease. Here, we investigated …

[HTML][HTML] CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration

…, S Sherrill-Mix, JK Everett, S Reddy… - The Journal of …, 2020 - Am Soc Clin Investig
Chimeric antigen receptor–engineered T cells targeting CD19 (CART19) provide an effective
treatment for pediatric acute lymphoblastic leukemia but are less effective for chronic …

Multiple introductions of SARS-CoV-2 alpha and delta variants into white-tailed deer in Pennsylvania

…, S Sherrill-Mix, JK Everett, H Adhikari, S Reddy… - MBio, 2022 - Am Soc Microbiol
The SARS-CoV-2 pandemic began by viral spillover from animals to humans; today multiple
animal species are known to be susceptible to infection. White-tailed deer, Odocoileus …

[PDF][PDF] INSPIIRED: a pipeline for quantitative analysis of sites of new DNA integration in cellular genomes

…, Y Wu, A Dryga, N Malani, F Male, S Reddy… - … Therapy-Methods & …, 2017 - cell.com
Integration of new DNA into cellular genomes mediates replication of retroviruses and
transposons; integration reactions have also been adapted for use in human gene therapy. …

A new grading system for retinal pigment epithelial tears

D Sarraf, S Reddy, A Chiang, F Yu, A Jain - Retina, 2010 - journals.lww.com
Purpose: The purpose of this study was to assess the prognostic value of a new grading
system for retinal pigment epithelium (RPE) tears that developed after antivascular endo-thelial …

Lentiviral globin gene therapy with reduced-intensity conditioning in adults with β-thalassemia: a phase 1 trial

…, AM Roche, VA Cantu, H Adhikari, S Reddy… - Nature medicine, 2022 - nature.com
β-Thalassemias are inherited anemias that are caused by the absent or insufficient production
of the β chain of hemoglobin. Here we report 6–8-year follow-up of four adult patients with …

Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency

…, AM Roche, P Hokama, S Reddy… - Blood, The Journal …, 2021 - ashpublications.org
Patients lacking functional adenosine deaminase activity have severe combined immunodeficiency
(ADA SCID), which can be treated with ADA enzyme replacement therapy (ERT), …